Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kammen

Showing results (541-550 of 549) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 549 results.
European Stroke Journal|September 29, 2023
Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopeniaJohannes Weller, Katarzyna Krzywicka, Anita van de Munckhof, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 18, 2024
Reducing the global burden of cerebral venous thrombosis: An international research agendaJonathan M Coutinho, Anita van de Munckhof, Diana Aguiar de Sousa, et al.
European Stroke Journal|April 4, 2024
Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19Adrian Scutelnic, Anita van de Munckhof, Angel T Miraclin, et al.
European Journal of Neurology|February 11, 2023
Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopeniaKatarzyna Krzywicka, Diana Aguiar de Sousa, Charlotte Cordonnier, et al.
The Lancet. Neurology|February 22, 2025
Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort studyAnita van de Munckhof, Mayte Sánchez van Kammen, Turgut Tatlisumak, et al.
JAMA Neurology|October 21, 2024
Development and Validation of a Clinical Score to Predict Epilepsy After Cerebral Venous ThrombosisErik Lindgren, Liqi Shu, Naaem Simaan, et al.
Stroke|September 9, 2022
Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute PhaseAnita van de Munckhof, Erik Lindgren, Timothy J Kleinig, et al.
Annals of Neurology|June 11, 2022
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationAdrian Scutelnic, Katarzyna Krzywicka, Joshua Mbroh, et al.
JAMA Neurology|September 28, 2021
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic ThrombocytopeniaMayte Sánchez van Kammen, Diana Aguiar de Sousa, Sven Poli, et al.
Pageof 55

Showing results (541-550 of 549) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 549 results.
European Stroke Journal|September 29, 2023
Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopeniaJohannes Weller, Katarzyna Krzywicka, Anita van de Munckhof, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 18, 2024
Reducing the global burden of cerebral venous thrombosis: An international research agendaJonathan M Coutinho, Anita van de Munckhof, Diana Aguiar de Sousa, et al.
European Stroke Journal|April 4, 2024
Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19Adrian Scutelnic, Anita van de Munckhof, Angel T Miraclin, et al.
European Journal of Neurology|February 11, 2023
Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopeniaKatarzyna Krzywicka, Diana Aguiar de Sousa, Charlotte Cordonnier, et al.
The Lancet. Neurology|February 22, 2025
Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort studyAnita van de Munckhof, Mayte Sánchez van Kammen, Turgut Tatlisumak, et al.
JAMA Neurology|October 21, 2024
Development and Validation of a Clinical Score to Predict Epilepsy After Cerebral Venous ThrombosisErik Lindgren, Liqi Shu, Naaem Simaan, et al.
Stroke|September 9, 2022
Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute PhaseAnita van de Munckhof, Erik Lindgren, Timothy J Kleinig, et al.
Annals of Neurology|June 11, 2022
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationAdrian Scutelnic, Katarzyna Krzywicka, Joshua Mbroh, et al.
JAMA Neurology|September 28, 2021
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic ThrombocytopeniaMayte Sánchez van Kammen, Diana Aguiar de Sousa, Sven Poli, et al.
Pageof 55